- About
-
Projects
-
Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
-
Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
-
Column 1
- News and Events
- Expanded Access eRequest
Announcements
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
Coverage
BIO’s collaboration in an industry-FDA roundtable earlier this year produced detailed recommendations published in June by the Reagan-Udall Foundation for the FDA.
In 2024, the Reagan-Udall Foundation for the FDA, a private nonprofit created by Congress during the Bush-era, held a roundtable with representatives of the food industry, from behemoths to influential restaurant groups.
How evidence supporting drug repurposing is submitted to the FDA and who reviews it are among the issues that must be addressed, former acting Commissioner Janet Woodcock said at a recent Reagan-Udall Foundation meeting.